Shifting attitudes and regulatory frameworks for cannabis and psilocybin in the United States may open the door for innovative approaches to pain management.
Thailand's Public Health Minister backs easing restrictions on medical use of opium and psilocybin but maintains position on cannabis and hemp extracts
While the government is primarily considering the economic potential of cannabis in international markets, there's a crucial need to meet domestic demand, including for medical purposes.
Cancer patients, people suffering from post-traumatic disorder, and wounded soldiers poised to benefit after Ukraine parliament passes historic law on medical cannabis
Japan moves one step forward and two steps back with efforts to legalise cannabis-based medicines while tightening policies on recreational use of cannabis.
Nelson and Dumbili introduce a special issue of 'Drugs, Habits and Social Policy' that sheds light on the social and structural drivers of opioid use in the continent, and the impacts of restrictive policy.
The shift towards synthetic drugs, coupled with prohibition-led unpredictable and toxic drug supplies, has sparked a harrowing overdose crisis in North America, demanding policy reforms that advance harm reduction and learn from the pitfalls of the 'war on drugs'.